U.S. markets closed

Akero Therapeutics, Inc. (AKRO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
31.06+1.17 (+3.91%)
At close: 4:00PM EST
Full screen
Loading interactive chart...
  • Akero Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
    Business Wire

    Akero Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

    Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced that management will present virtually at the 39th Annual J.P. Morgan Healthcare Conference at 10:50 a.m. EST on Tuesday, January 12, 2021.

  • Is AKRO A Good Stock To Buy Now?
    Insider Monkey

    Is AKRO A Good Stock To Buy Now?

    Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […]

  • Akero Therapeutics to Present at Evercore ISI 3rd Annual HealthCONx Virtual Conference
    Business Wire

    Akero Therapeutics to Present at Evercore ISI 3rd Annual HealthCONx Virtual Conference

    Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced that management will participate in a fireside chat at Evercore’s 3rd Annual HealthCONx virtual conference at 11:20 a.m. ET on Thursday, December 3, 2020.